Eversept Partners LP Cuts Stock Holdings in Revvity Inc. $RVTY

Eversept Partners LP decreased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 58.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 162,777 shares of the company’s stock after selling 231,534 shares during the period. Eversept Partners LP owned 0.14% of Revvity worth $15,749,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in Revvity by 15.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock valued at $44,821,000 after purchasing an additional 67,662 shares during the period. First National Bank of Omaha purchased a new position in Revvity during the 3rd quarter valued at about $6,432,000. Tudor Investment Corp ET AL purchased a new position in Revvity during the 3rd quarter valued at about $15,128,000. Neuberger Berman Group LLC increased its position in Revvity by 4,598.9% during the 3rd quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock valued at $40,358,000 after purchasing an additional 450,648 shares during the period. Finally, Elo Mutual Pension Insurance Co increased its position in Revvity by 46.2% during the 3rd quarter. Elo Mutual Pension Insurance Co now owns 19,199 shares of the company’s stock valued at $1,683,000 after purchasing an additional 6,066 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

RVTY has been the topic of a number of research reports. Stifel Nicolaus cut their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. JPMorgan Chase & Co. cut their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Weiss Ratings downgraded shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. TD Cowen lifted their price objective on shares of Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Barclays lifted their price objective on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Four research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $107.73.

Revvity Stock Down 3.5%

Shares of Revvity stock opened at $97.72 on Thursday. The firm’s 50 day moving average price is $95.57 and its 200-day moving average price is $97.62. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $118.30. The company has a market cap of $10.90 billion, a P/E ratio of 46.75, a PEG ratio of 2.21 and a beta of 1.11.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. During the same quarter in the previous year, the firm earned $1.01 EPS. The company’s quarterly revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts predict that Revvity Inc. will post 5.25 EPS for the current fiscal year.

Revvity Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s payout ratio is currently 13.40%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.